Mar T. S.
- Country
- Spain
- Department
- Departamento de Neurología
Research Overview
- Investigation of RO7121932 Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics in Multiple Sclerosis Patients
- A Phase 3 Non-inferiority Study Comparing Subcutaneous versus Intravenous Administration of Frexalimab in Adults with Multiple Sclerosis
- Phase III Open‑Label Single‑Arm Multicenter Study of On‑Body Delivery System for Subcutaneous High‑Concentration Ocrelizumab in Adults with Multiple Sclerosis
Data & Insights
Has run more than one trial at 199 of 408 partner sites.
Specializations
Neuroimmunology and Multiple Sclerosis
The investigator is involved in clinical research on inflammatory and immune-mediated disorders of the nervous system, with particular attention to multiple sclerosis and relapsing forms of demyelinating disease. The portfolio also extends to broader autoimmune neurology and conditions marked by immune dysregulation.
- Relapsing-remitting multiple sclerosis
- Primary progressive multiple sclerosis
- Secondary progressive multiple sclerosis
- Immune-mediated neurological disease
Research activity in this area reflects a strong therapeutic focus on disease control, symptom reduction, and long-term management of chronic neuroinflammatory conditions.
Neurodegenerative and Movement Disorders
Clinical trial involvement includes disorders affecting cognition and motor function, especially Alzheimer’s disease and Parkinson’s disease. This area also covers progressive neurological syndromes that affect mobility, coordination, and daily function.
- Alzheimer’s disease
- Parkinson’s disease
- Early symptomatic cognitive decline
- Neurodegenerative disorders
The investigator’s therapeutic interests include interventions aimed at slowing neurological deterioration and addressing functional impairment in chronic brain disease.
Headache and Epilepsy Disorders
The research landscape includes episodic and chronic headache syndromes together with seizure disorders. Trial activity spans migraine, focal epilepsy, and broader seizure disorders, reflecting an interest in disabling neurological symptoms that require long-term treatment strategies.
- Chronic migraine
- Episodic migraine
- Focal epilepsy
- Seizure disorders
This therapeutic area is linked to clinical innovation in symptom prevention, attack reduction, and improved neurological stability.
Neuromuscular and Rare Neurological Diseases
There is active involvement in rare and complex neurological conditions affecting muscle strength, neuromuscular transmission, and central nervous system development. The portfolio includes myasthenia gravis, inherited neuromuscular disorders, and severe childhood-onset neurological syndromes.
- Myasthenia gravis
- Muscular dystrophy
- Developmental and epileptic encephalopathies
- Rare neurogenetic disorders
The investigator’s clinical interests in this domain support therapeutic development for conditions with limited treatment options and substantial functional burden.
Stroke and Acute Neurological Care
Clinical research activity also reaches acute cerebrovascular disease, including ischemic stroke and related emergency neurological presentations. This area includes conditions requiring rapid intervention and secondary prevention in order to limit disability.
- Acute ischemic stroke
- Transient ischemic attack
- Hemorrhagic stroke
- Neurological emergency care
The therapeutic emphasis in this field is centered on improving outcomes in time-sensitive neurological disease and advancing care for patients at risk of recurrent events.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.